he Ca 2ϩ movements that control many cellular functions, including contraction of striated and smooth muscle cells and vesicular secretion from endocrine cells and nerve terminals, are increasingly recognized to involve macromolecular Ca 2ϩ -signaling complexes that, in addition to the key Ca 2ϩ -transporting proteins, include large numbers of associated proteins that provide a variety of regulatory, structural and Ca 2ϩ -sensing/buffering functions. The importance of working out the subtle interactions within these macromolecular complexes is underscored by the genetic diseases that have been associated with mutations of their constituent proteins.
In this issue, Terentyev et al 1 use a spectrum of molecular and electrophysiological techniques to demonstrate that triadin (TRD) plays an unexpectedly important role in regulating the ryanodine receptors (RyRs), found primarily in dyadic junctions of cardiac sarcoplasmic reticulum (SR; Figure) . It has been previously suggested that TRD and junctin are integral membrane proteins of the junctional SR, and serve as linker proteins from the SR Ca release channel (RyR) to calsequestrin (CSQ) complexes, the major Ca 2ϩ -buffer in the lumen of the SR (Figure) . 2 The large (Ϸ4500 aa) cytoplasmic domain of RyR appears to have multiple binding sites for an ever-growing list of proteins that includes: calmodulin, PKA, FKBP 12.6. 3 The major findings of the present communication are that overexpression of TRD leads to 3-fold increase in open probability of RyRs in bilayers, a 60% increase in spontaneous spark frequency with only minor decreases in spark amplitude (Ϸ10%) and SR Ca 2ϩ content (Ϸ30%), as well as a marked alteration in the voltage dependence of Ca 2ϩ release. The authors propose the activity of RyRs to be directly modulated by the level of expression of TRD, most likely mediated by amino acid residues 200 to 224 of TRD, associating with RyR in a manner similar to that of CSQ. They provide fairly clear evidence that these residues are critical for the described excitation-contraction (EC) coupling phenotype, as transfection of myocytes without this domain failed to alter the control EC coupling phenotype. Because a decrease of the Ca 2ϩ -content of the SR by 30% would have a direct inhibitory effect on the frequency of occurrence of spontaneous sparks and the open probability of RyRs as previously proposed, the observed increases in frequency of sparks and open probability of single RyRs is even more impressive, suggesting that TRD may be a more critical regulator of RyR activity, perhaps even more than luminal SR Ca 2ϩ concentrations. 4 which in turn inactivate the Ca 2ϩ channel helping to terminate the release process. 5 Deviations from a strict Ca 2ϩ -dependent process, however, were recognized early when quantifying the gain of CICR. It was surprising to find that the gain of CICR was voltage-dependent, showing Ϸ10ϫ higher gain at negative voltages of Ϫ30 to Ϫ40 mV where I Ca was minimally activated. Recent studies introducing small segments of the carboxylic tail (ie, LA peptide) 6 of the Ca 2ϩ channel ␣ 1c subunit into atrial myocytes suggest that only the apocalmodulin binding domain of the LA peptide was the critical domain required to enhance the spontaneous spark frequency and the gain factor of the Ca 2ϩ channel (dihydropyridine receptors [DHPR]) uncoupled central release sites. The specific interaction of the LA peptide with the RyR at Ϫ30 mV and Ϫ40 mV, but not at ϩ10 mV, could provide for the voltage-dependence of CICR, as well as the 4ϫ higher spontaneous frequency of peripheral Ca 2ϩ sparks (where DHPR and RyRs are coexpressed), as compared with the DHPR-uncoupled central sites of atrial myocytes. 6 These findings suggest that CICR mechanism maybe regulated also by molecular processes that could involve direct proteinprotein interaction.
Voltage-Dependence of CICR
In this issue, using adenoviral transfection of adult rat myocytes, Terentyev In contrast, large increases in Ca 2ϩ content of the SR by overexpression of the endogenous Ca 2ϩ buffering protein, cardiac CSQ via adenoviral approach, 9 or via the transgenic mice approach 10 failed to change the voltage-dependence of I Ca -triggered Ca 2ϩ release significantly, even though producing sharply opposite results on the efficacy of I Ca to release SR Ca 2ϩ . In myocytes overexpressing CSQ (adenoviral approach), there was a large enhancement of both caffeine-and I Ca -triggered Ca 2ϩ transients. 9 In transgenic CSQ overexpressing mice, I Ca -triggered Ca 2ϩ release was markedly suppressed, and coordinated activation of Ca 2ϩ sparks failed to occur, leading to smaller and slower Ca 2ϩ transients, even though caffeine triggered stores were 3 to 5ϫ larger than in wild mice. 10 In this model, interestingly, increasing the Ca 2ϩ sensitivity of RyRs with 0.2 to 0.5 mmol/L of caffeine restored coordinated sarcomeric Ca 2ϩ striping. 11 Irrespective of the differences in the 2 sets of data, the voltagedependence of I Ca -triggered Ca 2ϩ release was not significantly different between the 2 models, suggesting that CSQ serves a dual role in regulating CICR, ie, CSQ enhances Ca 2ϩ release by increasing SR Ca 2ϩ content and, at the same time, CSQ inhibits Ca 2ϩ release by its Ca 2ϩ -dependent binding to the RyR, possibly via its interaction with TRD. Consistent with this idea are in vitro data suggesting that CSQ binds to TRD (Figure) , and that both proteins together may represent the sarcoplasmic Ca 2ϩ sensor that regulates the intraluminal Ca 2ϩ sensitivity of the RyR. 12 When comparing the voltage-dependence of the Ca 2ϩ current of control and TRD overexpressing myocytes it becomes quite clear that even though there is no effect on I Ca , the ability of I Ca to trigger Ca 2ϩ release is strongly enhanced only when I Ca is very small, suggesting either an increased sensitivity of RyRs to Ca 2ϩ (easily testable from bilayer single RyRs studies), or that the gating of RyRs is fundamentally altered in TRD overexpressing myocytes. It is suprising to note that the Ca 2ϩ release actually may precede I Ca (Figure 2 of Terentyev et al), suggesting that the depolarization signal may directly regulate Ca 2ϩ release process similar to the mechanism of skeletal muscle. It is intriguing to consider whether the level of expression of TRD in part determines the "purity" of the CICR mechanism. If that were the case, does the higher expression of TRD drive the reaction toward a less Ca 2ϩ -dependent phenotype as found in skeletal muscle? In this respect it would be critical to determine the stoichiometry of TRD and RyR in control, and TRD-overexpressing myocytes, as well as in skeletal muscle. A cursory quantification of the gain of I Ca -gated Ca 2ϩ release, based on the data of their Figure 2 , suggests orders of magnitude increase in the amplification factor at Ϫ30 mV, Ϫ20 mV and ϩ60 mV, allowing the I Ca -induced Ca 2ϩ release to behave more like the depolarization-induced Ca 2ϩ release of skeletal muscle. Quantifying the gain of I Ca -gated Ca 2ϩ release corrected for the Ca 2ϩ content of SR as a ratio of the extent of TRD overexpression may provide critical insight in determining how TRD amplifies Ca 2ϩ release.
Adenovirus-Mediated Versus Transgenic TRD Overexpression
It should be noted that chronic overexpression of TRD in cardiac tissue via a transgenic approach resulted in a quite different EC coupling phenotype. Unlike the results from rat myocytes acutely overexpressing TRD presented by Terentyev et al in this current issue, 1 chronic overexpression of TRD in mouse myocytes increased spark amplitude, and SR Ca 2ϩ load, but did not change spark frequency. 13 Inactivation of I Ca was slowed, consistent with impaired CICR. 13 There are many possible reasons for the discrepancies between acute and chronic overexpression of TRD. For example, chronic overexpression of TRD causes down-regulation of the RyR and junctin, 14 which may in turn contribute to the observed differences in the TRD transgenic Ca 2ϩ signaling phenotype. On the other hand, keeping adult cardiomyocytes in culture for over 48 hours (necessary for the adenovirus transfection experiments) significantly changes myocyte structure and protein expression (ie, loss of t-tubules, downregulation of K-channels). Furthermore, in neither model system the exact subcellular location of the overexpressed TRD is known. Depending on the degree of association of the overexpressed TRD molecules with the native RyRs and their stoichiometry, the resultant phenotype could be quite different. For example, rapid production of TRD protein driven by a highly active adenovirus promoter may lead to TRD that is 
Arrhythmia and TRD
If indeed TRD is an important regulator of the SR Ca 2ϩ release channel (RyR, Figure) , as the data of Terentyev et al 1 suggest, it may not be surprising that TRD overexpression also would increase the proclivity for arrhythmogenesis in a manner similar the abnormalities of expression of other SR associated Ca 2ϩ -signaling proteins. Specifically, recent clinical data 15, 16 strongly suggest that mutations that render cardiac CSQ or RyR dysfunctional can cause a syndrome of catecholamine-induced polymorphic ventricular tachycardia (CPVT). The finding of catecholamine-induced Ca 2ϩ waves that trigger delayed after-depolarizations in TRD overexpressing myocytes reported here 1 resembles results obtained in myocytes that have decreased levels of functional CSQ 17 or harbor CPVT-linked RyR mutations. 18 Together, this raises the exciting possibility that mutations in or increased expression of TRD may represent a novel mechanism that could be responsible for the CPVT syndrome in humans. However, the data from transgenic mice with cardiac-targeted overexpression of TRD appear to suggest otherwise. It has been reported that chronic overexpression of TRD in mouse myocytes was not accompanied by catecholamine-induced arrhythmia, and Ca 2ϩ release was less sensitive to catecholamines. 13 Finally, TRD transgenic mice appeared to develop cardiac hypertrophy, 14 not a usual feature of the clinical CPVT syndrome.
What can we conclude? The data given by Terentyev et al 1 demonstrate that TRD plays a critical role in the regulation of EC coupling, clearly a major step forward. On the other hand, the large discrepancies of the experimental results between the adenovirus-based increased TRD expression levels reported here and TRD transgenic mice reported previously 13, 14 suggests that the function of TRD in regulation of CICR and cardiac pathophysiology maybe more complex than what might be predicted from the available data.
